The World Health Organization (WHO) said Nigeria had expressed interest in joining other parts of the world to show solidarity in the trial of vaccines developed for COVID-19.
The WHO Nigeria Officer-In-Charge and also a member of the Presidential Taskforce on COVID-19, Dr. Fiona Braka, made this known on Friday during the 24th joint national briefing of the PTF committee.
She made it known that seven clinical evaluation, 89 vaccines, and so many therapeutics are being developed globally to tackle the pandemic.
“Nigeria has also expressed interest to be part of this solidarity trial, and efforts are underway to start the process in Nigeria too.”
“Together with global health actors and partners, over the past week, WHO launched the Access to Covid-19 Tools ACT Accelerator, a global collaboration to accelerate development for equitable access to new Covid-19 diagnostics, therapeutics, and vaccines.
“We have a total of 89 vaccines that are in development globally, including seven in clinical evaluation, and some therapeutics are in clinical trials. WHO is committed to ensuring that as medicines and vaccines are developed, they are shared equitably with all countries and people.
“We do have the solidarity trial, which is an international clinical trial to help find an effective treatment for Covid-19, launched by the WHO and partners. More than 100 countries have joined the solidarity trial. To date, over 1,200 patients have been randomized from the first five countries to evaluate the safety and efficacy of full drug and drug combinations,” Braka said.